Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant

Emi Takashita; Noriko Kinoshita; Seiya Yamayoshi; Yuko Sakai-Tagawa; Seiichiro Fujisaki; Mutsumi Ito; Kiyoko Iwatsuki-Horimoto; Shiho Chiba; Peter Halfmann; Hiroyuki Nagai; Makoto Saito; Eisuke Adachi; David Sullivan; Andrew Pekosz; Shinji Watanabe; Kenji Maeda; Masaki Imai; Hiroshi Yotsuyanagi; Hiroaki Mitsuya; Norio Ohmagari; Makoto Takeda; Hideki Hasegawa; Yoshihiro Kawaoka

Journal ArticleOPEN ACCESS

Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant

Takashita E
Kinoshita N
Yamayoshi S
et al.

New England Journal of Medicine (2022) 386(10) 995-998

DOI: 10.1056/nejmc2119407

279Citations

195Readers

Abstract

Monoclonal Antibody and Antiviral Activity against Omicron Investigators assessed the in vitro activities of seven monoclonal antibodies and three antiviral drugs against Covid-19 variants of conce...

Cite

CITATION STYLE

APA

Takashita, E., Kinoshita, N., Yamayoshi, S., Sakai-Tagawa, Y., Fujisaki, S., Ito, M., … Kawaoka, Y. (2022). Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant. New England Journal of Medicine, 386(10), 995–998. https://doi.org/10.1056/nejmc2119407

Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant

Abstract

Cite

Register to see more suggestions